TARO PHARMACEUTICAL GETS TENTATIVE ANDA OK FOR TWO DRUGS

Taro Pharmaceuticals Industries Inc. (TARO) said Monday it received tentative approval from the U.S. Food and Drug Administration for its abbreviated new drug applications for carvedilol tablets and for ondansetron hydrochloride tablets.
Therapeutics Daily